[go: up one dir, main page]

FI20070162L - Method for controlled release of material from amphiphilic compounds and use of the method - Google Patents

Method for controlled release of material from amphiphilic compounds and use of the method Download PDF

Info

Publication number
FI20070162L
FI20070162L FI20070162A FI20070162A FI20070162L FI 20070162 L FI20070162 L FI 20070162L FI 20070162 A FI20070162 A FI 20070162A FI 20070162 A FI20070162 A FI 20070162A FI 20070162 L FI20070162 L FI 20070162L
Authority
FI
Finland
Prior art keywords
amphiphilic compounds
membrane
controlled release
amphiphilic
compounds
Prior art date
Application number
FI20070162A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20070162A7 (en
FI20070162A0 (en
Inventor
Lauri Paasonen
Timo Laaksonen
Kyoesti Kontturi
Arto Urtti
Original Assignee
Teknillinen Korkeakoulu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teknillinen Korkeakoulu filed Critical Teknillinen Korkeakoulu
Priority to FI20070162A priority Critical patent/FI20070162L/en
Publication of FI20070162A0 publication Critical patent/FI20070162A0/en
Priority to PCT/FI2008/000033 priority patent/WO2008104633A1/en
Publication of FI20070162A7 publication Critical patent/FI20070162A7/en
Publication of FI20070162L publication Critical patent/FI20070162L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)

Abstract

Method for releasing a material in a controlled manner from amphiphilic compounds. The material to be released is enclosed inside a membrane formed of an amphiphilic compound, in which or inside which membrane noble-metal nanoparticles are incorporated. Light of a sufficiently strong intensity is directed to the amphiphilic compounds for a sufficiently long time for the membrane to change phase, as a result of the increase in temperature, and to open an exit path for the material.
FI20070162A 2007-02-27 2007-02-27 Method for controlled release of material from amphiphilic compounds and use of the method FI20070162L (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20070162A FI20070162L (en) 2007-02-27 2007-02-27 Method for controlled release of material from amphiphilic compounds and use of the method
PCT/FI2008/000033 WO2008104633A1 (en) 2007-02-27 2008-02-27 Method for releasing a material in a controlled manner from amphiphilic compounds and use of the method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20070162A FI20070162L (en) 2007-02-27 2007-02-27 Method for controlled release of material from amphiphilic compounds and use of the method

Publications (3)

Publication Number Publication Date
FI20070162A0 FI20070162A0 (en) 2007-02-27
FI20070162A7 FI20070162A7 (en) 2008-08-28
FI20070162L true FI20070162L (en) 2008-08-28

Family

ID=37832207

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20070162A FI20070162L (en) 2007-02-27 2007-02-27 Method for controlled release of material from amphiphilic compounds and use of the method

Country Status (2)

Country Link
FI (1) FI20070162L (en)
WO (1) WO2008104633A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2544533A4 (en) * 2010-03-12 2014-07-09 Univ California TRIGGERED RELEASE OF THE CARGO OF STABILIZED NANOPARTICLE LIPOSOMES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5810888A (en) * 1997-06-26 1998-09-22 Massachusetts Institute Of Technology Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
ATE463342T1 (en) * 1999-07-16 2010-04-15 Univ Wm Marsh Rice TEMPERATURE DEPENDENT POLYMER/NANOSHELL COMPOSITE FOR PHOTOTHERMAL MODULATED DRUG DELIVERY
CA2399293C (en) * 2000-02-08 2012-01-03 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
DE10242367A1 (en) * 2002-09-12 2004-03-18 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Thermolabile liposomes with good stability in serum, e.g. for release of drugs or contrast agents in hyperthermic areas around tumors, formed from phosphatidyl choline(s) and phosphatidyl oligoglycerol
WO2005077330A1 (en) * 2004-02-17 2005-08-25 The University Of Melbourne Electromagnetic radiation addressable materials
US8048448B2 (en) * 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery

Also Published As

Publication number Publication date
WO2008104633A1 (en) 2008-09-04
FI20070162A7 (en) 2008-08-28
FI20070162A0 (en) 2007-02-27

Similar Documents

Publication Publication Date Title
CL2017001873A1 (en) Cannabinoid purification methods, compositions and kits thereof
CL2008003690A1 (en) Compounds derived from ammonobenzamide; pharmaceutical composition comprising the compounds; and use to control parasites.
SV2011003855A (en) HETEROARILOS SUBSTITUTED
DK2300443T3 (en) Triazole derivatives useful for the treatment of diseases
PL2509974T3 (en) Pyrazole derivatives as calcium channel modulators activated by calcium release and methods of treating non-small cell lung cancer
CL2011000527A1 (en) Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c.
SI3320912T1 (en) Immunotherapy based on indolamine 2,3-dioxygenase
CL2008003038A1 (en) Compounds derived from spiroheterocyclic pyrrolidine diones; process for the preparation of said compounds; pesticidal composition; method to combat and control pests; and intermediate compounds.
CR11827A (en) GLUCOQUINASE ACTIVATORS
DK2235000T3 (en) CHEMICAL MOLECULES INHIBITING THE splicing mechanism for the treatment of diseases caused by splicing anomalies
DK2315756T3 (en) 1,2,5-OXADIAZOLES AS INHIBITORS OF INDOLAMIN-2,3-DIOXYGENASE
BRPI0922680A2 (en) polymerizable composition for optical materials, optical material and method of manufacturing the same
DK3289876T3 (en) COMPOUNDS FOR THE TREATMENT OF CANCER
CL2008002460A1 (en) Compounds derived from bicyclic bisamide; pesticidal composition comprising said compounds; and method to control pests.
DK2029677T3 (en) Process for dry crushing of materials containing carbonate ore
WO2009111676A8 (en) Boron-containing small molecules as anti-inflammatory agents
CR20130184A (en) BIOACTIVE COMPOSITIONS OF CHROMOBACTERIUM AND METABOLITES
CL2012000921A1 (en) Compounds derived from spiropiperidine-methylbenzyloxyphenyl, activators of the rpg-40 receptor; pharmaceutical composition comprising them; and use of the compound to treat diabetes.
BRPI0916593A2 (en) process for continuous modification of dihydrate plaster and modified dihydrate plaster obtained through the process.
EP2332048A4 (en) CREATION OF SANDBOXES BY ALTERED TOKENS
EA201101116A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
CL2011000846A1 (en) Heterocyclic Substituted Compounds; pharmaceutical composition; and its use for the treatment of hepatitis c.
EA201101118A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
BRPI0814715A2 (en) PINK CONTAINING FLAVONA AND DELFINIDINE, AND METHOD FOR PRODUCTION OF THE SAME
GB0816678D0 (en) Wavelength monitored and stabilized source

Legal Events

Date Code Title Description
FD Application lapsed